[HTML] mdpi.com

[HTML][HTML] DNA damage response in cancer therapy and resistance: challenges and opportunities

D Jurkovicova, CM Neophytou, AČ Gašparović… - International Journal of …, 2022 - mdpi.com
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …
被引用次数：45 相关文章

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

D Jurkovicova, C Neophytou, A Gašparović… - … Journal of Molecular …, 2022 - europepmc.org
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

D Jurkovicova, CM Neophytou… - International …, 2022 - search.proquest.com
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

D Jurkovicova, CM Neophytou, AČ Gašparović… - 2022 - agris.fao.org
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

D Jurkovicova, CM Neophytou… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities.

D Jurkovicova, CM Neophytou… - International …, 2022 - search.ebscohost.com
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …
[HTML] nih.gov

[HTML][HTML] DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

D Jurkovicova, CM Neophytou… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities.

D Jurkovicova, CM Neophytou… - … Journal of Molecular …, 2022 - europepmc.org
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …